Our Liposomal Glutathione is: Third-party tested for purity and potency
This approach mirrors strategies used with other peptide therapies to optimize tolerability
Tendon and ligament healing This is where BPC-157 has the most research support
One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout
The AST-treated group showed significant improvement in muscle strength compared to the CPZ and sham groups
The multiyear project was initiated by Xingya Jiang PhD19, who is now a postdoctoral research fellow at Harvard Medical School/Brigham and Womens Hospital, and was continued by Qinhan Zhou, a PhD candidate in chemistry at UT Dallas
